These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11895493)
41. Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma. Zhang H; Jenkins SM; Lee CT; Harrington SM; Liu Z; Dong H; Zhang L Hum Pathol; 2018 Aug; 78():97-105. PubMed ID: 29698699 [TBL] [Abstract][Full Text] [Related]
42. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma. Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761 [TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898 [TBL] [Abstract][Full Text] [Related]
44. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes. Mittra I; Redkar AA; Badwe RA J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375 [TBL] [Abstract][Full Text] [Related]
45. Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms. Kuroki T; Tajima Y; Kanematsu T J Hepatobiliary Pancreat Surg; 2005; 12(6):463-6. PubMed ID: 16365819 [TBL] [Abstract][Full Text] [Related]
46. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma. Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628 [TBL] [Abstract][Full Text] [Related]
47. The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma. Aishima S; Taguchi K; Sugimachi K; Asayama Y; Nishi H; Shimada M; Sugimachi K; Tsuneyoshi M Int J Surg Pathol; 2002 Jan; 10(1):47-56. PubMed ID: 11927969 [TBL] [Abstract][Full Text] [Related]
48. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. Kajiyama K; Maeda T; Takenaka K; Sugimachi K; Tsuneyoshi M Am J Surg Pathol; 1999 Aug; 23(8):892-902. PubMed ID: 10435558 [TBL] [Abstract][Full Text] [Related]
50. Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma. Wang TT; Cao QH; Chen MY; Xia Q; Fan XJ; Ma XK; Lin Q; Jia CC; Dong M; Ruan DY; Lin ZX; Wen JY; Wei L; Li X; Chen ZH; Wang L; Wu XY; Wan XB PLoS One; 2013; 8(11):e80317. PubMed ID: 24303007 [TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Dong LW; Hou YJ; Tan YX; Tang L; Pan YF; Wang M; Wang HY Autophagy; 2011 Oct; 7(10):1222-9. PubMed ID: 21654208 [TBL] [Abstract][Full Text] [Related]
52. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery. Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737 [TBL] [Abstract][Full Text] [Related]
53. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. Gu MJ; Choi JH J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361 [TBL] [Abstract][Full Text] [Related]
54. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841 [TBL] [Abstract][Full Text] [Related]
55. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology. Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816 [TBL] [Abstract][Full Text] [Related]
56. IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma. Gao Y; Yang M; Jiang Z; Woda BA; Mercurio AM; Qin J; Huang X; Zhang F Hum Pathol; 2014 Jun; 45(6):1184-91. PubMed ID: 24745619 [TBL] [Abstract][Full Text] [Related]
57. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin. Guedj N; Vaquero J; Clapéron A; Mergey M; Chrétien Y; Paradis V; Fouassier L Histopathology; 2016 Aug; 69(2):211-21. PubMed ID: 26791814 [TBL] [Abstract][Full Text] [Related]
58. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods]. Wang X; Zhang J; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495 [TBL] [Abstract][Full Text] [Related]
59. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma. Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565 [TBL] [Abstract][Full Text] [Related]
60. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]